Status:
COMPLETED
Relative Bioavailability of a Fentanyl Patch
Lead Sponsor:
Sandoz
Conditions:
Pain
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.
Eligibility Criteria
Inclusion
- No clinically significant abnormal findings on physical exam, medical history or clinical laboratory tests on screening.
Exclusion
- Negative test for HIV and hepatitis B and C
- No history of drug or alcohol treatment
- No allergies to opiates
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00857753
Start Date
September 1 2006
End Date
October 1 2006
Last Update
March 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.